Key Record Dates
ClinicalTrials.gov Identifier: | NCT03278665 |
---|---|
Brief Title: | 4SC-202 in Combination With Pembrolizumab in Patients Primary Refractory/Non-responding to Prior Anti-PD-1 Therapy (SENSITIZE) |
First Submitted : | September 5, 2017 |
First Submitted that Met QC Criteria : | September 11, 2017 |
First Posted : | September 12, 2017 |
Last Update Submitted that Met QC Criteria : | September 11, 2020 |
Last Update Posted : | September 14, 2020 |